Annual FCF
-$68.17 M
+$10.27 M+13.09%
31 December 2023
Summary:
AC Immune SA annual free cash flow is currently -$68.17 million, with the most recent change of +$10.27 million (+13.09%) on 31 December 2023. During the last 3 years, it has fallen by -$2.86 million (-4.39%). ACIU annual FCF is now -226.97% below its all-time high of $53.68 million, reached on 31 December 2019.ACIU Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$12.81 M
-$93.46 M-115.89%
01 September 2024
Summary:
AC Immune SA quarterly free cash flow is currently -$12.81 million, with the most recent change of -$93.46 million (-115.89%) on 01 September 2024. Over the past year, it has increased by +$3.18 million (+19.88%). ACIU quarterly FCF is now -115.89% below its all-time high of $80.64 million, reached on 30 June 2024.ACIU Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$51.34 M
+$3.18 M+6.60%
01 September 2024
Summary:
AC Immune SA TTM free cash flow is currently $51.34 million, with the most recent change of +$3.18 million (+6.60%) on 01 September 2024. Over the past year, it has increased by +$121.17 million (+173.51%). ACIU TTM FCF is now -6.99% below its all-time high of $55.20 million, reached on 30 September 2019.ACIU TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACIU Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.1% | +19.9% | +173.5% |
| 3 y3 years | -4.4% | +20.1% | +168.5% |
| 5 y5 years | -45.2% | -172.4% | -7.0% |
ACIU Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -4.4% | +13.1% | -115.9% | +50.0% | at high | +162.7% |
| 5 y | 5 years | -227.0% | +13.1% | -115.9% | +50.0% | -7.0% | +162.7% |
| alltime | all time | -227.0% | +13.1% | -115.9% | +50.0% | -7.0% | +162.7% |
AC Immune SA Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$12.81 M(-115.9%) | $51.34 M(+6.6%) |
| June 2024 | - | $80.64 M(+8993.8%) | $48.16 M(-198.4%) |
| Mar 2024 | - | $886.80 K(-105.1%) | -$48.92 M(-28.2%) |
| Dec 2023 | -$68.17 M(-13.1%) | -$17.38 M(+8.7%) | -$68.17 M(-2.4%) |
| Sept 2023 | - | -$15.99 M(-2.7%) | -$69.83 M(+2.8%) |
| June 2023 | - | -$16.44 M(-10.5%) | -$67.95 M(-4.5%) |
| Mar 2023 | - | -$18.36 M(-3.6%) | -$71.15 M(-9.3%) |
| Dec 2022 | -$78.44 M(+4.9%) | -$19.05 M(+35.0%) | -$78.44 M(-1.9%) |
| Sept 2022 | - | -$14.11 M(-28.2%) | -$79.93 M(-2.3%) |
| June 2022 | - | -$19.64 M(-23.4%) | -$81.85 M(+1.9%) |
| Mar 2022 | - | -$25.64 M(+24.8%) | -$80.35 M(+7.5%) |
| Dec 2021 | -$74.76 M(+14.5%) | -$20.54 M(+28.1%) | -$74.76 M(-0.3%) |
| Sept 2021 | - | -$16.03 M(-11.7%) | -$74.95 M(-3.2%) |
| June 2021 | - | -$18.15 M(-9.5%) | -$77.40 M(+3.0%) |
| Mar 2021 | - | -$20.04 M(-3.3%) | -$75.12 M(+15.0%) |
| Dec 2020 | -$65.30 M(-221.6%) | -$20.73 M(+12.1%) | -$65.30 M(+11.5%) |
| Sept 2020 | - | -$18.49 M(+16.6%) | -$58.54 M(+161.8%) |
| June 2020 | - | -$15.86 M(+55.0%) | -$22.36 M(+0.5%) |
| Mar 2020 | - | -$10.23 M(-26.8%) | -$22.26 M(-141.5%) |
| Dec 2019 | $53.68 M | -$13.97 M(-178.9%) | $53.68 M(-2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $17.69 M(-212.3%) | $55.20 M(+118.2%) |
| June 2019 | - | -$15.75 M(-124.0%) | $25.30 M(-25.5%) |
| Mar 2019 | - | $65.71 M(-627.5%) | $33.96 M(-172.3%) |
| Dec 2018 | -$46.96 M(+93.6%) | -$12.46 M(+2.1%) | -$46.96 M(+71.8%) |
| Sept 2018 | - | -$12.20 M(+72.0%) | -$27.34 M(+14.9%) |
| June 2018 | - | -$7.09 M(-53.4%) | -$23.79 M(-12.0%) |
| Mar 2018 | - | -$15.21 M(-312.2%) | -$27.03 M(+11.4%) |
| Dec 2017 | -$24.26 M(+265.1%) | $7.17 M(-182.8%) | -$24.26 M(-37.4%) |
| Sept 2017 | - | -$8.65 M(-16.3%) | -$38.74 M(+78.7%) |
| June 2017 | - | -$10.34 M(-16.8%) | -$21.68 M(+94.8%) |
| Mar 2017 | - | -$12.43 M(+69.8%) | -$11.13 M(+67.5%) |
| Dec 2016 | -$6.64 M(-114.6%) | -$7.32 M(-187.0%) | -$6.64 M(+33.2%) |
| Sept 2016 | - | $8.41 M(+3831.0%) | -$4.99 M(-123.9%) |
| June 2016 | - | $213.90 K(-102.7%) | $20.90 M(+28.4%) |
| Mar 2016 | - | -$7.95 M(+40.3%) | $16.27 M(-64.3%) |
| Dec 2015 | $45.56 M(-334.5%) | -$5.66 M(-116.5%) | $45.56 M(-11.1%) |
| Sept 2015 | - | $34.30 M(-876.9%) | $51.22 M(+202.7%) |
| June 2015 | - | -$4.42 M(-120.7%) | $16.92 M(-20.7%) |
| Mar 2015 | - | $21.34 M | $21.34 M |
| Dec 2014 | -$19.42 M | - | - |
FAQ
- What is AC Immune SA annual free cash flow?
- What is the all time high annual FCF for AC Immune SA?
- What is AC Immune SA annual FCF year-on-year change?
- What is AC Immune SA quarterly free cash flow?
- What is the all time high quarterly FCF for AC Immune SA?
- What is AC Immune SA quarterly FCF year-on-year change?
- What is AC Immune SA TTM free cash flow?
- What is the all time high TTM FCF for AC Immune SA?
- What is AC Immune SA TTM FCF year-on-year change?
What is AC Immune SA annual free cash flow?
The current annual FCF of ACIU is -$68.17 M
What is the all time high annual FCF for AC Immune SA?
AC Immune SA all-time high annual free cash flow is $53.68 M
What is AC Immune SA annual FCF year-on-year change?
Over the past year, ACIU annual free cash flow has changed by +$10.27 M (+13.09%)
What is AC Immune SA quarterly free cash flow?
The current quarterly FCF of ACIU is -$12.81 M
What is the all time high quarterly FCF for AC Immune SA?
AC Immune SA all-time high quarterly free cash flow is $80.64 M
What is AC Immune SA quarterly FCF year-on-year change?
Over the past year, ACIU quarterly free cash flow has changed by +$3.18 M (+19.88%)
What is AC Immune SA TTM free cash flow?
The current TTM FCF of ACIU is $51.34 M
What is the all time high TTM FCF for AC Immune SA?
AC Immune SA all-time high TTM free cash flow is $55.20 M
What is AC Immune SA TTM FCF year-on-year change?
Over the past year, ACIU TTM free cash flow has changed by +$121.17 M (+173.51%)